Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. - Wikidata - awgldk - TriplyDB

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

http://www.wikidata.org/entity/Q46954392

about

Psychosocial Factors in Diabetes and Cardiovascular Risk Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapy Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries Drug-eluting stents in patients with chronic kidney disease: a prospective registry study Short-term consequences of angiographically-confirmed coronary stent thrombosis Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?Incidence of side-effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation.The effect of cilostazol on stent thrombosis after drug-eluting stent implantation Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST])Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE study Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow.Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?Simultaneous very late stent thrombosis in multiple coronary arteries.Clinical presentations, antiplatelet strategies and prognosis of patients with stent thrombosis: an observational study of 140 patients.Painting blood vessels and atherosclerotic plaques with an adhesive drug depot Progressive stent technologies: new approaches for the treatment of cardiovascular diseases.Late thrombosis a concern with drug-eluting stents.Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease.Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes.Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practice Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization Off-label use of stents: bare-metal versus drug-eluting stents.Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis.Stent thrombosis is a major concern in clinical practice: A single Saudi center experience Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury Development of biodegradable crosslinked urethane-doped polyester elastomers.

P2860

Q28070388-0BEEFDA0-F9FB-4C8F-932E-2239DD998115 Q28218066-5FB3563F-9654-454B-BC27-858A34217F35 Q28221675-116AF35B-25BF-4EE0-9E28-FC760C6FC269 Q28476360-1567B407-0D1B-4E1F-A62A-56DDBE5D7BEF Q28534401-5BF24FEF-1441-424B-A716-F0BD3B295926 Q28545192-E5B00065-CEAA-4B9C-A422-D935B2DDA112 Q30910604-A34619A2-0580-44EE-8473-D5B3931B48A6 Q33410893-2D72BF39-C23A-4D4E-AE95-AD729126F73B Q33616230-3CD2870D-1FFF-4610-BAA5-99107FBDFB7C Q33839384-E78313FE-7384-494F-B7C6-AF412A86195F Q33854333-1D1C7FFA-2149-4F00-B64C-1199D7FD9D57 Q34420671-B59324F5-B736-45E7-845C-A3C3FBC8BDF2 Q34531925-EC5FEA97-0D97-4962-9010-D9CBF9047032 Q34726838-9239FB41-E3C3-420F-93E7-D18659986676 Q35154464-EA2D1A5A-F9E3-4C32-91FD-9B7BAD1CEDD1 Q35755253-1C887F2D-F8E7-46E5-9892-8B73AD78251D Q35878281-E233BADA-131F-4F23-BD05-AD0CC184567E Q35927978-BBCB6019-8033-4713-9DEB-B7376301743F Q36086140-59DE6E97-2D63-43D7-B57B-D496A12F3231 Q36145722-3DA2E46C-215C-428E-8A24-F14C5E99E851 Q36205310-8876B8C3-AAC1-4C95-94DE-99789E633CC0 Q36289544-BCAAACAF-17BC-440A-A606-1E72E76A28E4 Q36360516-5C847BB7-F097-458B-9917-44161CFAC468 Q36504186-62D38ABC-9724-429A-80C4-DADFA6744D9A Q36640339-67EB4E50-766C-4742-9887-A4E9D91B6C7B Q36735679-B055B0A0-E083-49F1-9B26-EF731344B6EC Q36804733-3F41B085-504C-473A-AD4F-5DB6A0D0A69C Q36941850-2CEF2C5F-93FC-47F9-809A-D28DE8D7697F Q36995923-C3642797-31A2-42CF-B152-91A837904102 Q37016139-F74A734F-D261-4CF5-BA15-0931E18E2051 Q37048954-45E71990-877A-4242-8955-B542E1607778 Q37086357-0823638D-6BA3-4618-A3AB-85D71C6DB1D7 Q37134004-AE5A8DD2-465C-41D4-AEF1-0B66CA0DA1E6 Q37140881-F09DC8D5-D46F-4BDC-BB25-591BCB4803BF Q37167506-FB25B053-63E3-4C65-8103-2C319E9D9A96 Q37269384-1BE37431-5D81-4DB3-B6B9-3E096B37CA1C Q37269388-EFB2A2B6-CA6B-4452-A94D-5AA57BC6E8C5 Q37282855-7A3598C7-4CED-4922-8A04-6FF8A4D5F2B9 Q37306731-FB826CB4-865D-4A4F-B467-FCEDD500CA28 Q37354923-A156CB8D-8FFF-4E53-B61E-266C7EE5482A

P2860

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

http://www.wikidata.org/entity/Q46954392

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@en

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@nl

type

label

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@en

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@nl

prefLabel

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@en

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@nl

P1433

Q46954392-6C112FC7-7208-4259-AD90-040D6C0F51BE

P1476

Q46954392-E6ED7F2D-A0F4-4C51-9A82-9707CA03DDB4

P2093

Q46954392-07A97C72-9144-479A-BBC3-518F4D35CF1D

Q46954392-20F8A960-9F8C-4876-BA0C-17CEF6BB3BEA

Q46954392-21094C11-7685-4C3B-ADD8-0EE6BFFA2058

Q46954392-24044091-8CBC-4678-9305-26CFE28F2B01

Q46954392-38439833-78B2-4E0B-963B-51553FAB35AF

Q46954392-45C33350-E6A2-489A-9316-A4200F69EADA

Q46954392-54968E36-C2BE-4A1C-9FE7-C95190C08C00

Q46954392-659D35D0-24A5-4A97-8DA7-F8FA8ACCCABA

Q46954392-780DCBCA-FABC-4E38-8FC4-703F6E8AF607

Q46954392-9A8DC48D-F20E-4858-BA5F-87416D602E9F

P304

Q46954392-A8FA7872-A805-4E00-B73F-2021AD814356

P31

Q46954392-65660B30-B8BB-48AE-AF8B-9880F0E339D6

P356

Q46954392-5D7D97A2-D9F3-4AFD-90AF-1AA4C8C62852

P407

Q46954392-F9F76A8E-215E-4FBE-8A75-2692EB1DB018

P433

Q46954392-C514688A-FAA8-4CD8-B749-23B589F2F21A

P478

Q46954392-B2036784-A945-4566-9F74-43F8B2ACAAC2

P577

Q46954392-190F1185-3CDB-4F56-A1D3-A96FCC25A7CE

P698

Q46954392-71CC99D6-49C8-433A-B8AA-D0FE36345E9D

P921

Q46954392-960DE4DD-1229-43F1-B608-9F4CBCC0A1EE

Q46954392-C3EA8D9C-9670-4734-8DC8-03A858FAD79C

P356

CIRCULATIONAHA.105.600155

P1433

P1476

Correlates and long-term outco ...... and paclitaxel-eluting stents.

@en

P2093

Ahn Bui

http://www.w3.org/2001/XMLSchema#string

Augusto D Pichard

http://www.w3.org/2001/XMLSchema#string

Jana Fournadjieva

http://www.w3.org/2001/XMLSchema#string

Kenneth M Kent

http://www.w3.org/2001/XMLSchema#string

Kimberly Smith

http://www.w3.org/2001/XMLSchema#string

Leonardo C Clavijo

http://www.w3.org/2001/XMLSchema#string

Lowell F Satler

http://www.w3.org/2001/XMLSchema#string

Natalie Gevorkian

http://www.w3.org/2001/XMLSchema#string

Patrick Ohlmann

http://www.w3.org/2001/XMLSchema#string

Pramod K Kuchulakanti

http://www.w3.org/2001/XMLSchema#string

P304

1108-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.105.600155

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16490815

http://www.w3.org/2001/XMLSchema#string

P921